Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.08)
# 3,836
Out of 5,149 analysts
81
Total ratings
33.33%
Success rate
-14.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Equal-Weight | $8 → $6 | $5.10 | +17.65% | 4 | Feb 26, 2026 | |
| CTEV Claritev | Maintains: Equal-Weight | $33 → $30 | $16.91 | +77.41% | 2 | Feb 24, 2026 | |
| WAY Waystar Holding | Maintains: Overweight | $41 → $36 | $26.58 | +35.44% | 2 | Feb 19, 2026 | |
| DOCS Doximity | Maintains: Overweight | $55 → $45 | $26.97 | +66.85% | 14 | Feb 6, 2026 | |
| PHR Phreesia | Initiates: Overweight | $30 | $12.37 | +142.52% | 1 | Jan 9, 2026 | |
| HNGE Hinge Health | Initiates: Overweight | $68 | $44.36 | +53.29% | 1 | Jan 9, 2026 | |
| OMDA Omada Health | Initiates: Equal-Weight | $17 | $13.00 | +30.77% | 1 | Jan 9, 2026 | |
| OMCL Omnicell | Maintains: Overweight | $43 → $52 | $40.80 | +27.45% | 18 | Jan 5, 2026 | |
| VEEV Veeva Systems | Maintains: Overweight | $341 → $333 | $185.91 | +79.12% | 9 | Nov 25, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $1.72 | +190.70% | 7 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $9 | $5.15 | +74.76% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $2.07 | +238.16% | 8 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $125 | $80.43 | +55.41% | 9 | Feb 26, 2025 |
Teladoc Health
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $8 → $6
Current: $5.10
Upside: +17.65%
Claritev
Feb 24, 2026
Maintains: Equal-Weight
Price Target: $33 → $30
Current: $16.91
Upside: +77.41%
Waystar Holding
Feb 19, 2026
Maintains: Overweight
Price Target: $41 → $36
Current: $26.58
Upside: +35.44%
Doximity
Feb 6, 2026
Maintains: Overweight
Price Target: $55 → $45
Current: $26.97
Upside: +66.85%
Phreesia
Jan 9, 2026
Initiates: Overweight
Price Target: $30
Current: $12.37
Upside: +142.52%
Hinge Health
Jan 9, 2026
Initiates: Overweight
Price Target: $68
Current: $44.36
Upside: +53.29%
Omada Health
Jan 9, 2026
Initiates: Equal-Weight
Price Target: $17
Current: $13.00
Upside: +30.77%
Omnicell
Jan 5, 2026
Maintains: Overweight
Price Target: $43 → $52
Current: $40.80
Upside: +27.45%
Veeva Systems
Nov 25, 2025
Maintains: Overweight
Price Target: $341 → $333
Current: $185.91
Upside: +79.12%
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $1.72
Upside: +190.70%
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $5.15
Upside: +74.76%
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.07
Upside: +238.16%
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $80.43
Upside: +55.41%